跳至主要内容
临床试验/DRKS00010478
DRKS00010478招募中不适用

Prospective, open, multicentre observational clinical study to inves- tigate safety and efficacy of cell-free Autologous Conditioned Serum (ACS) in patients with knee osteoarthritis with 3 years follow-up - OrthoR

ORTHOGEN AG0 个研究点目标入组 1,000 人开始时间: 2016年11月14日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
1,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
30 Years 至 80 Years(—)
性别
All

入选标准

  • 1) Confirmed Knee OA (Kellgren-Lawrence Grades II–IV) diagnosis with imaging proceders (e.g. x-ray, CT, MRI) not older than 6 month
  • 2) Knee pain for at least 4 weeks and pain intensity NRS =5
  • 3) Treatment initiation with ACS
  • 4) Signed informed written Patient´s Informed Consent Form

排除标准

  • 1) Previous knee operations in the last 6 months (Surgery and/or diagnostic arthroscopy)
  • 2) History of clinically significant trauma
  • 3) Intra-articular injections in the last 3 months with steroids, hyaluronate compounds or PRP, ACS, ACP
  • 4) RA or autoimmune cause of arthritis, systemic bone or joint illnesses
  • 5) Active inflammation of predominant patella-femoral disease
  • 6) BMI>30
  • 7) Malignancy
  • 8) Infection
  • 9) Pregnancy

研究者

发起方
ORTHOGEN AG

相似试验